Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide.
- 1 February 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (3) , 999-1003
- https://doi.org/10.1073/pnas.91.3.999
Abstract
Like many pathogens that undergo an intravascular stage of development, larvae of the helminth parasite Schistosoma mansoni migrate through the blood vessels, where they are in close contact with endothelial cells. In vitro exposure of murine endothelial cells to various cytokines (interferon gamma, tumor necrosis factor alpha, and interleukin 1 alpha or 1 beta) resulted in their activation to kill schistosomula through an arginine-dependent mechanism involving production of nitric oxide (NO). Cytokine-treated endothelial cells showed increased expression of mRNA for the inducible form of the NO synthase, and both NO production and larval killing were suppressed by treatment with competitive inhibitors. The effector function of cytokine-treated endothelial cells was similar to that of activated inflammatory tissue macrophages, although activation appeared to be differentially regulated in these two cell types. Activated endothelial cells killed older (18-day) forms of the parasite, such as those currently thought to be a primary target of immune elimination in the lungs of mice previously vaccinated with radiation-attenuated cercariae, as well as newly transformed larvae. In C57BL/6 mice, which become resistant to S. mansoni infection as a result of vaccination with irradiated cercariae, endothelial cell morphology characteristic of activation was observed in the lung by 1-2 weeks after challenge infection. Similar endothelial cell changes were absent in P-strain mice, which do not become resistant as a result of vaccination. Together, these observations indicate that endothelial cells, not traditionally considered to be part of the immune system, may play an important role in immunity to S. mansoni and, by means of NO-dependent killing, could serve as effectors of resistance to other intravascular pathogens.Keywords
This publication has 25 references indexed in Scilit:
- Mammalian cell lines can be efficiently established in vitro upon expression of the SV40 large T antigen driven by a promoter sequence derived from the human vimentin genePublished by Wiley ,2012
- Lymphocyte interactions with endothelial cellsImmunology Today, 1992
- Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.Proceedings of the National Academy of Sciences, 1992
- Combined Microautoradiographic and Histopathologic Analysis of the Fate of Challenge Schistosoma Mansoni Schistosomula in Mice Immunized with Irradiated CercariaeThe American Journal of Tropical Medicine and Hygiene, 1992
- Nitric oxide mediates tumor necrosis factor-α cytotoxicity in endothelial cellsBiochemical and Biophysical Research Communications, 1992
- IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.The Journal of Immunology, 1992
- Cytokine regulation of endothelial cell functionThe FASEB Journal, 1992
- Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factorsMicrovascular Research, 1992
- Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts.The Journal of Immunology, 1991
- Morphological Basis of Pulmonary Edema in Mice with Cytokine-Induced Vascular Leak SyndromeExperimental Lung Research, 1991